Inaccuracy of Sodium Measurement in Patients with Severe Hypernatremia

Author(s):  
Amir Karin ◽  
Davor Brinc ◽  
Felix Leung ◽  
Benjamin P Jung

Abstract Introduction We observed discordant sodium results from a patient with severe hypernatremia such that whole-blood analysis produced results up to 9.6 mmol/L higher than plasma sodium obtained on the same collection. We investigated this bias by comparing other patients’ sodium results and performing comparisons of 3 blood gas and 2 chemistry analyzers. Methods First, the laboratory information system was queried for whole-blood sodium results >160 mmol/L, which were used for comparison against plasma results from the same collection. Second, whole blood was collected from a healthy donor, a portion of which was spiked with sodium chloride to generate 8 samples with target concentrations of 140 to 185 mmol/L. Whole-blood sodium was measured in duplicate on the ABL90, RAPIDPoint 500, and GEM 4000. Plasma sodium was then measured in duplicate on the Architect c8000 and Cobas c702. Finally, plasma was injected on the blood gas analyzers to measure sodium in singleton. Results Overall, 53 paired results from patients showed a significant positive bias on the ABL90 relative to Vitros when sodium was >160 mmol/L. The magnitude of difference was insignificant within the reference range but increased proportionately with concentration. The magnitude and pattern of positive bias in ABL90 sodium results were consistent with the observation in patient results. Conclusion In severe hypernatremia, sodium results produced by blood gas and plasma analyzers can differ significantly.

2014 ◽  
Vol 22 (10) ◽  
pp. 2733-2739 ◽  
Author(s):  
范建华 FAN Jian-hua ◽  
邓永波 DENG Yong-bo ◽  
宣明 XUAN Ming ◽  
周松 ZHOU Song ◽  
武俊峰 WU Jun-feng ◽  
...  

Bioanalysis ◽  
2019 ◽  
Vol 11 (19) ◽  
pp. 1737-1754 ◽  
Author(s):  
Paul Abu-Rabie ◽  
Bikalpa Neupane ◽  
Neil Spooner ◽  
James Rudge ◽  
Philip Denniff ◽  
...  

Aim: Collection and quantitative analysis in dry blood using volumetric absorptive microsampling (VAMS™) potentially offers significant advantages over conventional wet whole blood analysis. This manuscript explores their use for pediatric sampling and explores additional considerations for the validation of the bioanalytical method. Results: HPLC–MS/MS methods for the determination of midazolam and its major metabolite 1-OH midazolam in both whole wet blood, and dry blood collected on VAMS were developed, validated, and used to support an observational clinical study to compare pharmacokinetic parameters in pediatric patients. Conclusion: Validation data met internationally accepted guideline criteria. A strong correlation was observed in calculated concentrations between wet and dry test samples, indicating that VAMS is a suitable technique for use in pediatric clinical studies.


1976 ◽  
Vol 3 (2) ◽  
pp. 91-94 ◽  
Author(s):  
J. J. Malanify ◽  
C. E. Burns ◽  
D. A. Close ◽  
R. C. Bearse

1981 ◽  
Vol 181 (1-3) ◽  
pp. 305-308 ◽  
Author(s):  
B. Spoelstra ◽  
J.P.F. Sellschop ◽  
H.J. Annegarn ◽  
M.J. Renan

Lab on a Chip ◽  
2013 ◽  
Vol 13 (13) ◽  
pp. 2634 ◽  
Author(s):  
Tingjie Li ◽  
Yaxi Fan ◽  
Yang Cheng ◽  
Jun Yang

Sign in / Sign up

Export Citation Format

Share Document